» Articles » PMID: 37226783

Non-coding RNAs in Precursor Lesions of Colorectal Cancer: Their Role in Cancer Initiation and Formation

Overview
Journal Curr Mol Med
Specialty Molecular Biology
Date 2023 May 25
PMID 37226783
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is one of the world's most common types of malignancy. The proliferation of precancerous lesions causes this type of cancer. Two distinct pathways for CRC carcinogenesis have been identified: the conventional adenoma-carcinoma pathway and the serrated neoplasia pathway. Recently, evidence has demonstrated the regulatory roles of noncoding RNAs (ncRNAs) in the initiation and progression of precancerous lesions, especially in the adenoma-carcinoma pathway and serrated neoplasia pathway. By expanding the science of molecular genetics and bioinformatics, several studies have identified dysregulated ncRNAs that function as oncogenes or tumor suppressors in cancer initiation and formation by diverse mechanisms via intracellular signaling pathways known to act on tumor cells. However, many of their roles are still unclear. This review summarizes the functions and mechanisms of ncRNAs (such as long non-coding RNAs, microRNAs, long intergenic non-coding RNAs, small interfering RNAs, and circRNAs) in the initiation and formation of precancerous lesions.

Citing Articles

RNA splicing variants of the novel long non-coding RNA, CyKILR, possess divergent biological functions in non-small cell lung cancer.

Xie X, Macknight H, Lu A, Chalfant C Mol Ther Nucleic Acids. 2025; 36(1):102412.

PMID: 39807365 PMC: 11728077. DOI: 10.1016/j.omtn.2024.102412.


The implication of TET1, miR-200, and miR-494 expression with tumor formation in colorectal cancer: through targeting Wnt signaling.

Tajali R, Zali N, Naderi Noukabadi F, Jalili M, Valinezhad M, Ghasemian F Mol Biol Rep. 2024; 51(1):1119.

PMID: 39495308 PMC: 11535070. DOI: 10.1007/s11033-024-10060-3.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Onyoh E, Hsu W, Chang L, Lee Y, Wu M, Chiu H . The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management. Curr Gastroenterol Rep. 2019; 21(8):36. DOI: 10.1007/s11894-019-0703-8. View

3.
Oines M, Helsingen L, Bretthauer M, Emilsson L . Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol. 2017; 31(4):419-424. DOI: 10.1016/j.bpg.2017.06.004. View

4.
Malki A, ElRuz R, Gupta I, Allouch A, Vranic S, Moustafa A . Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. Int J Mol Sci. 2020; 22(1). PMC: 7794761. DOI: 10.3390/ijms22010130. View

5.
Nikolouzakis T, Vassilopoulou L, Fragkiadaki P, Sapsakos T, Papadakis G, Spandidos D . Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review). Oncol Rep. 2018; 39(6):2455-2472. PMC: 5983921. DOI: 10.3892/or.2018.6330. View